Clinical Trial Update: A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating therapeutic equivalence between Respirent Fluticasone Propionate 100 mcg inhalation powder and GlaxoSmithKline FLOVENT DISKUS 100 mcg i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FLOVENT DISKUS 100 mcg (fluticasone propionate)
• Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder (Respirent Pharmaceuticals) (fluticasone propionate)

Snippet

Sponsor: Respirent Pharmaceuticals Co Ltd. | Conditions: Asthma | Phase 3 | Status: COMPLETED